glp-1 digital health news research2guidance GLP-1 Medications Infographic | Medidex
Description
The implications are significant: Repurposing an inexpensive, widely available drug Targeting the intersection of inflammasome activation, TP53 dysfunction, and neoplastic risk Potential relevance for disorders ranging from CAPS and histiocytosis to MDS and beyond We urgently need more translational work on this underappreciated molecule
There is some data bearing this out
Weekly dosage schedule Starting dose: 0.25 mg weekly for first 4 weeks Titration phase: 0.5 mg weekly for 4 weeks and then, if tolerated, 1 mg weekly for 4 weeks Maintenance dose for long-term weight management: 1.7 mg once weekly for 4 weeks and then, if tolerated, 2.4 mg once weekly (maximum dose) Dosing considerations If you do not tolerate dose escalation, consult with your healthcare provider and consider delaying the dose escalation for at least 4 weeks
Focus more on total dietary fiber intake, however, below are some of the best soluble fiber sources
PARTICIPANTS/MATERIALS, SETTING, METHODS We identified periconceptional liraglutide or semaglutide exposure (prescription redemption within 8 weeks before/after last menstrual period) using the National Prescription Register
[DOI] [PMC free article] [PubMed] [Google Scholar] 37.Sanyal A.J., Newsome P.N., Kliers I., et al
